Quantification of amikacin in bronchial epithelial lining fluid in neonates

Antimicrobial Agents and Chemotherapy

Volumn 55, Issue 9, 2011, Pages 3990-3993

  Tayman, C ^a   El Attug, M N ^b,d   Adams, E ^b   Van Schepdael, A ^b   Debeer, A ^c   Allegaert, K ^c   Smits, A ^c  

^a FATIH UNIVERSITY   (Turkey)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^d UNIVERSITY OF TRIPOLI   (Libyan Arab Jamahiriya)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; IBUPROFEN; UREA;

ARTICLE; ASPHYXIA; ASSISTED VENTILATION; BLOOD SAMPLING; BRONCHIAL EPITHELIAL LINING FLUID; BRONCHUS MUCOSA; CAPACITIVELY COUPLED CONTACTLESS CONDUCTIVITY DETECTION; CAPILLARY ELECTROPHORESIS; CLINICAL ARTICLE; DILUTION; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG HALF LIFE; DRUG MONITORING; ELECTRIC CAPACITANCE; ELECTROCHEMICAL DETECTION; FEMALE; HUMAN; LIQUID CHROMATOGRAPHY; LUNG INFECTION; LUNG LAVAGE; MALE; MAXIMUM PLASMA CONCENTRATION; NEWBORN; NEWBORN HYPOXIA; PERINATAL PERIOD; PRIORITY JOURNAL; PULSED ELECTROCHEMICAL DETECTION; TIME TO MAXIMUM PLASMA CONCENTRATION; UREA BLOOD LEVEL;

AMIKACIN; BODY FLUIDS; BRONCHI; BRONCHOALVEOLAR LAVAGE FLUID; EPITHELIUM; FEMALE; HUMANS; INFANT, NEWBORN; MALE; PROSPECTIVE STUDIES;

EID: 80051820160     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00277-11     Document Type: Article

References (27)

1. Allegaert, K., et al. 2004. Effects of co-administration of ibuprofen-lysine on the pharmacokinetics of amikacin in preterm infants during the first days of life. Biol. Neonate 86:207-211. (Pubitemid 39370289)
2. Allegaert, K., et al. 2008. Cerebrospinal fluid compartmental pharmacokinetics of amikacin in neonates. Antimicrob. Agents Chemother. 52:1934-1939. (Pubitemid 351758526)
3. Allegaert, K., I. Scheers, V. Cossey, and B J Anderson. 2008. Covariates of amikacin clearance in neonates: The impact of postnatal age on predictability. Drug Metab. Lett. 2:286-289.
4. Been, J V, et al. 2010. Early alterations of growth factor patterns in bronchoalveolar lavage fluid from preterm infants developing bronchopulmonary dysplasia. Pediatr. Res. 67:83-89.
5. Boselli, E., et al. 2007. Reliability of mini-bronchoalveolar lavage for the measurement of epithelial ling fluid concentrations of tobramycin in critically ill patients. Intensive Care Med. 33:1519-1523. (Pubitemid 47312468)
6. Brajanoski, G., J. Hoogmartens, K. Allegaert, E. Adams. 2008. Determination of amikacin in cerebrospinal fluid by high-performance liquid chromatography with pulsed electrochemical detection. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 867:149-152.
7. Braude, A C, A. Hornstein, M. Klein, S. Vas, and A S Rebuck. 1983. Pulmonary disposition of tobramycin. Am. Rev. Respir. Dis. 127:563-565. (Pubitemid 13087062)
8. Canis, F., et al. 1997. Pharmacokinetics and bronchial diffusion of single daily dose amikacin in cystic fibrosis patients. J. Antimicrob. Chemother. 39:431-433. (Pubitemid 27153807)
9. Carcas, J., J L Garcia-Satue, P. Zapater, and J. Frias-Iniesta. 1999. Tobramycin penetration into epithelial ling fluid of patients with pneumonia. Clin. Pharmacol. Ther. 65:245-250. (Pubitemid 29142930)
10. Dargaville, P A, M. South, P. Vervaart, and P N McDougall. 1999. Validity of markers of dilution in small volume lung lavage. Am. J. Respir. Crit. Care Med. 160:778-784. (Pubitemid 29442008)
11. De Blic, J., et al. 2000. Bronchoalveolar lavage in children. Eur. Respir. J. 15:217-231. (Pubitemid 30068965)
12. Dull, W L, M R Alexander, and J E Kasik. 1979. Bronchial secretion levels of amikacin. Antimicrob. Agents Chemother. 16:767-771. (Pubitemid 10082032)
13. Grigg, J., S. Amon, and M. Silverman. 1992. Fractional processing of sequential bronchoalveolar lavage fluid from intubated babies. Eur. Respir. J. 5:727-732.
14. Kiem, S, and J J Schentag. 2008. Interpretation of antibiotic concentration ratios measured in epithelial lining fluid. Antimicrob. Agents Chemother. 52:24-36.
15. Kotecha, S. 1999. Bronchoalveolar lavage of newborn infants. Pediatr. Pulmonol. Suppl. 18:122-124. (Pubitemid 29140330)
16. Langhendries, J P, et al. 1998. Adaptation in neonatology of the once-daily concept of aminoglycoside administration: Evaluation of a dosing chart for amikacin in an intensive care unit. Biol. Neonate 74:351-362. (Pubitemid 28461753)
17. Levy, J., D. Baran, and J. Klastersky. 1982. Comparative study of the antibacterial Activity of amikacin and tobramycin during Pseudomonas pulmonary infection in patients with cystic fibrosis. J. Antimicrob. Chemother. 10:227-234. (Pubitemid 13253891)
18. Luyt, C-E, et al. 2009. Pharmacokinetics and lung delivery of PDDS-aerosolized amikacin (NKTR-061) in intubated and mechanically ventilated patients with nosocomial pneumonia. Crit. Care 13:R200.
19. Mazzei, T., A. Novelli, F. De Lalla, E. Mini, and P. Periti. 1995. Tissue penetration and pulmonary disposition of tobramycin. J. Chemother. 7:363-370.
20. Mombelli, G., L. Coppens, F P Thys, and J. Klastersky. 1981. Anti-Pseudomonas activity in bronchial secretions of patients receiving amikacin or tobramycin as a continuous infusion. Antimicrob. Agents Chemother. 19: 72-75. (Pubitemid 11132462)
21. Odio, W., E. Van Laer, J. Klastersky. 1975. Concentrations of Gentamicin in bronchial secretions after intramuscular and endotracheal administration. J. Clin. Pharmacol. 15:518-524.
22. Panidis, D., S L Markantonis, E. Boutzouka, S. Karatzas, and G. Baltopoulos. 2005. Penetration of gentamicin into the alveolar lining fluid of critically ill patients with ventilator-associated pneumonia. Chest 128:545-552. (Pubitemid 41140478)
23. Santré, C., et al. 1995. Amikacin levels in bronchial secretions of 10 pneumonia patients with respiratory support treated once daily versus twice daily. Antimicrob. Agents Chemother. 39:264-267.
24. Schuchert-Shi, A, and P C Hauser. 2008. Monitoring the enzymatic conversion of urea to ammonium by conventional or microchip capillary electrophoresis with contactless conductivity detection. Anal. Biochem. 376:262-267.
25. Sherwin, C M T, et al. 2009. Individualised dosing of amikacin in neonates: A pharmacokinetic / pharmacodynamic analysis. Eur. J. Clin. Pharmacol. 65:705-713.
26. Valcke, Y J, D P Vogelaers, F A Colardyn, and A. Pauwels. 1992. Penetration of netilmicin in the lower respiratory tract after once-daily dosing. Chest 101:1028-1032.
27. Watts, C L, and M C Bruce. 1995. Comparison of secretory component for immunoglobulin A with albumin as reference proteins in tracheal aspirate from preterm infants. J. Pediatr. 127:113-122.